Apomorphine recalls

The FDA has published 2 recalls involving Apomorphine since 2016. The latest was reported on 1 Feb 2023. Most were for sterility. Pharmacy Innovations has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2016

Last 12 months0reported

Class I00% of total

Ongoing0latest 1 Feb 2023

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why apomorphine is recalled

Sterility2100%

Companies

Pharmacy Innovations150%
Pharmacy Plus150%

By year

2023150%
2016150%

All apomorphine recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
1 Feb 2023Drug	CLASS II	Apomorphine HCL 2MG/ML vial) Injectable recalled by Pharmacy Innovations	Pharmacy Innovations	Sterility	Nationwide
5 Oct 2016Drug	CLASS II	Apomorphine HCl 3mg/ml Sterile Injection Solution, MDV, Rx recalled	Pharmacy Plus	Sterility	MS

Should you stop taking Apomorphine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.